AV-608

N/A

Report date: 2022/11/25 16:34:12
NME

Base Information

Drug NameAV-608
Drug Alias NameNKP-608NK-608CGP-60829NKP-608CAV-608
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptor
Therapy Area/IndicationsPhobia, SocialUrinary Bladder, OveractiveIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvera Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPhobia, SocialUrinary Bladder, OveractiveIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksDrugBank